Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Operations

v2.3.0.15
Condensed Consolidated Statements Of Operations (USD $)
In Thousands, except Per Share data
3 Months Ended 9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Revenues:        
Product $ 12,199 $ 9,491 $ 33,528 $ 24,250
Collaborative research and development 19,201 17,243 54,073 49,450
Government grants 1,882 379 2,771 3,593
Total revenues 33,282 27,113 90,372 77,293
Costs and operating expenses:        
Cost of product revenues 9,958 8,563 28,713 19,856
Research and development 16,786 13,070 45,502 39,056
Selling, general and administrative 8,871 7,940 27,160 25,192
Total costs and operating expenses 35,615 29,573 101,375 84,104
Loss from operations (2,333) (2,460) (11,003) (6,811)
Interest income 76 61 195 135
Interest expense and other, net (411) (35) (378) (1,047)
Loss before provision for income taxes (2,668) (2,434) (11,186) (7,723)
Provision for income taxes 74 298 68 324
Net loss $ (2,742) $ (2,732) $ (11,254) $ (8,047)
Net loss per share of common stock, basic and diluted $ (0.08) $ (0.08) $ (0.32) $ (0.38)
Weighted average common shares used in computing net loss per share of common stock, basic and diluted 35,919 34,200 35,576 21,272